Article Information
History
- June 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lauren M. Sosinski1,
- Christian Martin H1,
- Kerri A. Neugebauer1,
- Lydia-Ann J. Ghuneim1,
- Douglas V. Guzior1,2,
- Alicia Castillo-Bahena3,
- Jenna Mielke4,
- Ryan Thomas5,
- Marc McClelland3,
- Doug Conrad4 and
- Robert A. Quinn1,*
- 1Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA
- 2Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, USA
- 3Spectrum Health, Grand Rapids, MI, USA
- 4Department of Medicine, University of California San Diego, La Jolla, CA
- 5Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI, USA
- ↵*To whom the correspondence should be addressed: Robert Quinn. Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA. Email: quinnrob{at}msu.edu
Author contributions: LS, CMH, KN, LJG, DVG generated data; LS, CMH, KN and RAQ analyzed data, ACB, JM collected samples: MM, RT and DC recruited patients; LM, CMH, KN, and RAQ wrote the paper; RAQ obtained funding for the project
Posted June 04, 2021.
Trikafta therapy alters the CF lung mucus metabolome reshaping microbiome niche space
